Company / CIK 0001237831
GLOBUS MEDICAL INC
- Ticker
- GMED
- Size, estimated from filings
- Large cap ($10B – $200B)
- Insiders on file
- 13
- Members of Congress who traded it
- 1
- Federal contracts on record
- 26 awards
- Lobbying filings on record
- 5
- SEC filings
- EDGAR ↗
- Latest trade on record
- September 15, 2026
GLOBUS MEDICAL INC (GMED) has 13 insiders on file who disclosed 61 transactions in the last 12 months (0 open-market buys, 14 sales, about $27.4M at reported prices), and 3 congressional trades in its stock are on record. USAspending shows 26 federal contract awards with a combined value of $252K to a recipient with this name that started in the last 180 days, and 3 lobbying filings naming it as client report $0 in 2026.
GLOBUS MEDICAL INC in charts
Who is trading this stock
Which people account for the buying and selling over the last 12 months?
BoughtSold
8 people account for the disclosed buying and selling in GLOBUS MEDICAL INC over the last 12 months; the most active is ZARRILLI STEPHEN T with $4.3M.
Federal contracts by agency
Which agencies awarded GLOBUS MEDICAL INC contracts that started in the last 180 days?
Federal contract awards to GLOBUS MEDICAL INC that started in the last 180 days have a combined award value of $252K, most from Department of Defense.
Insiders
| Name | Role | Rows | Bought | Sold | Last filed |
|---|---|---|---|---|---|
| TOBIN JAMES R | Director | 6 | 0 | 1 | September 16, 2026 |
| ZARRILLI STEPHEN T | Director | 7 | 0 | 2 | August 19, 2026 |
| DeFord John A | Director | 1 | 0 | 0 | August 3, 2026 |
| Davidar David D | Director | 9 | 0 | 2 | July 28, 2026 |
| RHOADS ANN D | Director | 5 | 0 | 2 | June 8, 2026 |
| Norwalk Leslie V | Director | 3 | 0 | 2 | May 15, 2026 |
| Huller Kelly | EVP, GC, Corporate Secretary | 10 | 0 | 3 | February 27, 2026 |
| Kline Kyle | Senior Vice President, CFO | 13 | 0 | 2 | January 23, 2026 |
| Wolterman Dan | Director | 1 | 0 | 0 | January 23, 2026 |
| Lemaitre Dan | Director | 1 | 0 | 0 | January 23, 2026 |
| Douglas Robert Andrew | Director | 1 | 0 | 0 | January 23, 2026 |
| Paul David C | Executive Chairman | 3 | 0 | 0 | January 23, 2026 |
| Pfeil Keith W | President, CEO | 1 | 0 | 0 | January 23, 2026 |
Rows are this company's Form 4 rows for each person. "Bought" and "sold" count open-market purchases (code P) and sales only. More in insider buying and insider selling.
Members of Congress who traded GMED
From periodic transaction reports that name the company's stock. Amounts are the sums of the ranges as filed. Every row is on the GMED page.
| Member | Seat | Trades | Bought | Sold | Range as filed | Latest |
|---|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. | Representative (CA, District 31), Democrat | 3 | 3 | 0 | $17K–$80K | September 3, 2026 |
Insider transactions
| Filer | Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TOBIN JAMES R | GMED | Option / conversion M | September 15, 2026 | September 16, 2026 | 1d | 15,000 | — | — | derivative | Form 4 ↗ | |
| TOBIN JAMES R | GMED | Option / conversion M | September 15, 2026 | September 16, 2026 | 1d | 15,000 | — | — | derivative | Form 4 ↗ | |
| TOBIN JAMES R | GMED | Sell S | September 15, 2026 | September 16, 2026 | 1d | 30,000 | $75 | $2.2M | Form 4 ↗ | ||
| TOBIN JAMES R | GMED | Option / conversion M | September 15, 2026 | September 16, 2026 | 1d | 15,000 | $64 | $955K | Form 4 ↗ | ||
| TOBIN JAMES R | GMED | Option / conversion M | September 15, 2026 | September 16, 2026 | 1d | 15,000 | $54 | $806K | Form 4 ↗ | ||
| ZARRILLI STEPHEN T | GMED | Option / conversion M | August 18, 2026 | August 19, 2026 | 1d | 25,000 | — | — | derivative | Form 4 ↗ | |
| ZARRILLI STEPHEN T | GMED | Sell S | August 18, 2026 | August 19, 2026 | 1d | 25,000 | $87 | $2.2M | Form 4 ↗ | ||
| ZARRILLI STEPHEN T | GMED | Option / conversion M | August 18, 2026 | August 19, 2026 | 1d | 25,000 | $53 | $1.3M | Form 4 ↗ | ||
| Davidar David D | GMED | Other G | July 27, 2026 | July 28, 2026 | 1d | 2,500 | — | — | Form 4 ↗ | ||
| Davidar David D | GMED | Option / conversion M | June 5, 2026 | June 9, 2026 | 4d | 25,000 | — | — | derivative | Form 4 ↗ | |
| Davidar David D | GMED | Sell S | June 5, 2026 | June 9, 2026 | 4d | 25,000 | $81 | $2.0M | Form 4 ↗ | ||
| Davidar David D | GMED | Option / conversion M | June 5, 2026 | June 9, 2026 | 4d | 25,000 | $26 | $657K | Form 4 ↗ | ||
| RHOADS ANN D | GMED | Option / conversion M | June 4, 2026 | June 8, 2026 | 4d | 25,000 | — | — | derivative | Form 4 ↗ | |
| RHOADS ANN D | GMED | Option / conversion M | June 4, 2026 | June 8, 2026 | 4d | 25,000 | $26 | $657K | Form 4 ↗ | ||
| Huller Kelly | GMED | Option / conversion M | February 25, 2026 | February 27, 2026 | 2d | 20,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Huller Kelly | GMED | Sell S | February 25, 2026 | February 27, 2026 | 2d | 20,000 | $95 | $1.9M | 10b5-1 plan | Form 4 ↗ | |
| Huller Kelly | GMED | Option / conversion M | February 25, 2026 | February 27, 2026 | 2d | 20,000 | $44 | $872K | 10b5-1 plan | Form 4 ↗ | |
| Huller Kelly | GMED | Option / conversion M | February 12, 2026 | February 17, 2026 | 5d | 10,000 | — | — | late10b5-1 planderivative | Form 4 ↗ | |
| Huller Kelly | GMED | Sell S | February 12, 2026 | February 17, 2026 | 5d | 10,000 | $88 | $877K | late10b5-1 plan | Form 4 ↗ | |
| Huller Kelly | GMED | Option / conversion M | February 12, 2026 | February 17, 2026 | 5d | 10,000 | $46 | $456K | late10b5-1 plan | Form 4 ↗ | |
| Norwalk Leslie V | GMED | Other A | January 21, 2026 | January 23, 2026 | 2d | 15,000 | — | — | derivative | Form 4 ↗ | |
| Pfeil Keith W | GMED | Other A | January 21, 2026 | January 23, 2026 | 2d | 100,000 | — | — | derivative | Form 4 ↗ | |
| Kline Kyle | GMED | Other A | January 21, 2026 | January 23, 2026 | 2d | 30,000 | — | — | derivative | Form 4 ↗ | |
| Paul David C | GMED | Other A | January 21, 2026 | January 23, 2026 | 2d | 100,000 | — | — | derivative | Form 4 ↗ | |
| Douglas Robert Andrew | GMED | Other A | January 21, 2026 | January 23, 2026 | 2d | 15,000 | — | — | derivative | Form 4 ↗ | |
| Lemaitre Dan | GMED | Other A | January 21, 2026 | January 23, 2026 | 2d | 15,000 | — | — | derivative | Form 4 ↗ | |
| RHOADS ANN D | GMED | Other A | January 21, 2026 | January 23, 2026 | 2d | 15,000 | — | — | derivative | Form 4 ↗ | |
| TOBIN JAMES R | GMED | Other A | January 21, 2026 | January 23, 2026 | 2d | 15,000 | — | — | derivative | Form 4 ↗ | |
| ZARRILLI STEPHEN T | GMED | Other A | January 21, 2026 | January 23, 2026 | 2d | 15,000 | — | — | derivative | Form 4 ↗ | |
| DeFord John A | GMED | Other A | January 21, 2026 | January 23, 2026 | 2d | 15,000 | — | — | derivative | Form 4 ↗ | |
| Wolterman Dan | GMED | Other A | January 21, 2026 | January 23, 2026 | 2d | 15,000 | — | — | derivative | Form 4 ↗ | |
| Davidar David D | GMED | Other A | January 21, 2026 | January 23, 2026 | 2d | 15,000 | — | — | derivative | Form 4 ↗ | |
| Huller Kelly | GMED | Other A | January 21, 2026 | January 23, 2026 | 2d | 40,000 | — | — | derivative | Form 4 ↗ | |
| Kline Kyle | GMED | Option / conversion M | January 8, 2026 | January 12, 2026 | 4d | 3,594 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Kline Kyle | GMED | Sell S | January 8, 2026 | January 12, 2026 | 4d | 3,594 | $101 | $363K | 10b5-1 plan | Form 4 ↗ | |
| Kline Kyle | GMED | Option / conversion M | January 8, 2026 | January 12, 2026 | 4d | 3,594 | $52 | $186K | 10b5-1 plan | Form 4 ↗ | |
| Norwalk Leslie V | GMED | Sell S | January 8, 2026 | January 12, 2026 | 4d | 2,000 | $101 | $202K | 10b5-1 plan | Form 4 ↗ | |
| Davidar David D | GMED | Other G | January 2, 2025 | January 5, 2026 | 368d | 6,100 | — | — | late | Form 4 ↗ | |
| Norwalk Leslie V | GMED | Sell S | December 12, 2025 | December 16, 2025 | 4d | 4,000 | $89 | $355K | 10b5-1 plan | Form 4 ↗ | |
| Paul David C | GMED | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 34,375 | — | — | derivative | Form 4 ↗ | |
| Paul David C | GMED | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 34,375 | $26 | $877K | Form 4 ↗ | ||
| Kline Kyle | GMED | Option / conversion M | December 1, 2025 | December 3, 2025 | 2d | 5,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Kline Kyle | GMED | Option / conversion M | December 1, 2025 | December 3, 2025 | 2d | 5,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Kline Kyle | GMED | Option / conversion M | December 1, 2025 | December 3, 2025 | 2d | 5,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Kline Kyle | GMED | Option / conversion M | December 1, 2025 | December 3, 2025 | 2d | 3,646 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Kline Kyle | GMED | Sell S | December 1, 2025 | December 3, 2025 | 2d | 18,542 | $90 | $1.7M | 10b5-1 plan | Form 4 ↗ | |
| Kline Kyle | GMED | Option / conversion M | December 1, 2025 | December 3, 2025 | 2d | 4,896 | $64 | $312K | 10b5-1 plan | Form 4 ↗ | |
| Kline Kyle | GMED | Option / conversion M | December 1, 2025 | December 3, 2025 | 2d | 5,000 | $64 | $322K | 10b5-1 plan | Form 4 ↗ | |
| Kline Kyle | GMED | Option / conversion M | December 1, 2025 | December 3, 2025 | 2d | 5,000 | $56 | $282K | 10b5-1 plan | Form 4 ↗ | |
| Kline Kyle | GMED | Option / conversion M | December 1, 2025 | December 3, 2025 | 2d | 3,646 | $53 | $194K | 10b5-1 plan | Form 4 ↗ | |
| Huller Kelly | GMED | Option / conversion M | November 25, 2025 | November 28, 2025 | 3d | 7,500 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Huller Kelly | GMED | Sell S | November 25, 2025 | November 28, 2025 | 3d | 7,500 | $90 | $675K | 10b5-1 plan | Form 4 ↗ | |
| Huller Kelly | GMED | Option / conversion M | November 25, 2025 | November 28, 2025 | 3d | 7,500 | $26 | $195K | 10b5-1 plan | Form 4 ↗ | |
| Davidar David D | GMED | Option / conversion M | November 12, 2025 | November 13, 2025 | 1d | 25,000 | — | — | derivative | Form 4 ↗ | |
| Davidar David D | GMED | Sell S | November 12, 2025 | November 13, 2025 | 1d | 25,000 | $86 | $2.2M | Form 4 ↗ | ||
| Davidar David D | GMED | Option / conversion M | November 12, 2025 | November 13, 2025 | 1d | 25,000 | $26 | $638K | Form 4 ↗ | ||
| ZARRILLI STEPHEN T | GMED | Option / conversion M | November 11, 2025 | November 13, 2025 | 2d | 25,000 | — | — | derivative | Form 4 ↗ | |
| ZARRILLI STEPHEN T | GMED | Sell S | November 11, 2025 | November 13, 2025 | 2d | 25,000 | $84 | $2.1M | Form 4 ↗ | ||
| ZARRILLI STEPHEN T | GMED | Option / conversion M | November 11, 2025 | November 13, 2025 | 2d | 25,000 | $44 | $1.1M | Form 4 ↗ | ||
| RHOADS ANN D | GMED | Sell S | November 10, 2025 | November 10, 2025 | 0d | 2,000 | $85 | $170K | 10b5-1 plan | Form 4 ↗ | |
| RHOADS ANN D | GMED | Sell S | November 7, 2025 | November 10, 2025 | 3d | 8,000 | $81 | $648K | 10b5-1 plan | Form 4 ↗ |
Federal contracts (USAspending, awards started in the last 180 days)
| Start date | Awarding agency | Award value | NAICS | Source |
|---|---|---|---|---|
| May 27, 2026 | Department of Defense | $32,973 | 423450 | USAspending ↗ |
| June 25, 2026 | Department of Defense | $23,991 | 423450 | USAspending ↗ |
| June 24, 2026 | Department of Defense | $20,575 | 423450 | USAspending ↗ |
| May 28, 2026 | Department of Defense | $17,409 | 423450 | USAspending ↗ |
| April 30, 2026 | Department of Defense | $15,708 | 423450 | USAspending ↗ |
| May 8, 2026 | Department of Defense | $15,258 | 423450 | USAspending ↗ |
| May 20, 2026 | Department of Defense | $15,215 | 423450 | USAspending ↗ |
| May 27, 2026 | Department of Defense | $15,007 | 423450 | USAspending ↗ |
| May 22, 2026 | Department of Defense | $14,979 | 423450 | USAspending ↗ |
| May 27, 2026 | Department of Defense | $10,442 | 423450 | USAspending ↗ |
| May 15, 2026 | Department of Defense | $8,333 | 423450 | USAspending ↗ |
| June 16, 2026 | Department of Defense | $7,854 | 423450 | USAspending ↗ |
| May 6, 2026 | Department of Defense | $7,854 | 423450 | USAspending ↗ |
| May 15, 2026 | Department of Defense | $7,854 | 423450 | USAspending ↗ |
| May 6, 2026 | Department of Defense | $5,499 | 423450 | USAspending ↗ |
| May 1, 2026 | Department of Defense | $5,480 | 423450 | USAspending ↗ |
| May 27, 2026 | Department of Defense | $5,461 | 423450 | USAspending ↗ |
| June 4, 2026 | Department of Defense | $5,186 | 423450 | USAspending ↗ |
| May 8, 2026 | Department of Defense | $4,554 | 423450 | USAspending ↗ |
| May 4, 2026 | Department of Defense | $4,554 | 423450 | USAspending ↗ |
| May 11, 2026 | Department of Defense | $2,692 | 423450 | USAspending ↗ |
| May 20, 2026 | Department of Defense | $1,402 | 423450 | USAspending ↗ |
| May 13, 2026 | Department of Defense | $1,402 | 423450 | USAspending ↗ |
| June 3, 2026 | Department of Defense | $1,100 | 423450 | USAspending ↗ |
| May 29, 2026 | Department of Defense | $776 | 423450 | USAspending ↗ |
| June 2, 2026 | Department of Defense | $429 | 423450 | USAspending ↗ |
Lobbying (Senate LDA, as client)
| Period | Registrant | Primary issue | Amount | Source |
|---|---|---|---|---|
| 2026 Q3 | BALLARD SPAHR LLP | — | — | LDA ↗ |
| 2026 Q2 | BALLARD SPAHR LLP | — | — | LDA ↗ |
| 2026 Q1 | BALLARD SPAHR LLP | — | — | LDA ↗ |
| 2025 Q4 | BALLARD SPAHR LLP | — | — | LDA ↗ |
| 2025 Q3 | BALLARD SPAHR LLP | — | — | LDA ↗ |
Related companies
Companies whose stock was traded by the same people who traded GMED, by number of filers in common. It shows overlap in public filings and nothing else.
- CrowdStrike Holdings, Inc. CRWD 1 filer in common
- Cloudflare, Inc. NET 1 filer in common
- Uber Technologies, Inc UBER 1 filer in common
- Datadog, Inc. DDOG 1 filer in common
- CARVANA CO. CVNA 1 filer in common
- Arista Networks, Inc. ANET 1 filer in common
- Credo Technology Group Holding Ltd CRDO 1 filer in common
- AppLovin Corp APP 1 filer in common
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Federal contracts: how to read USAspending data Obligation = money the government has committed. Outlay = money actually paid.
- Lobbying disclosure reports Reports are due about 20 days after each quarter ends.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| House Clerk, periodic transaction reports | 3 | 3 | April 7, 2026 | October 12, 2026 | House Clerk search |
| SEC EDGAR, Form 4 | 30 | 61 | November 10, 2025 | September 16, 2026 | Form 4 list on EDGAR |
| USAspending, federal contract awards | 26 awards | — | — | — | USAspending |
| Lobbying disclosure filings | 5 filings | — | — | — | LDA.gov search |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Insiders and their transactions come from SEC EDGAR Form 4 filings for this issuer. Contracts and lobbying are matched by exact normalized name (suffixes like Inc./Corp. ignored) to USAspending recipients and LDA clients — a conservative match that misses subsidiaries on purpose. See methodology and corrections.
Not investment advice. Public records shown as filed; no recommendation is made or implied.